Description
A partial agonist of GPR109A/HCA2 receptors (Ki = 0.55 μM in a radioligand binding assay); stimulates [35S]-GTPγS binding and increases phosphorylation of ERK in HEK293T cells expressing GPR109A/HCA2 receptors (EC50s = 3.1 and 0.32 μM, respectively); reduces plasma levels of VLDL and hepatic expression of apolipoprotein B in mice at 400 mg/kg per day ,
Formal name: 5-butyl-1H-pyrazole-3-carboxylic acid
Synonyms:
Molecular weight: 168.2
CAS: 92933-48-7
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Agonists||Research Area|Cardiovascular System|Lipids & Lipoproteins|Lipoproteins